| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiplatelets for secondary stroke prevention in China
|
Wu, Simiao
|
|
|
22 |
6 |
p. 457-459
|
article
|
| 2 |
A sensitive portrayal of a controversial condition
|
Stirrups, Robert
|
|
|
22 |
6 |
p. 473
|
article
|
| 3 |
Aspiring to restore arm and hand function after stroke
|
Hayward, Kathryn S
|
|
|
22 |
6 |
p. 464-465
|
article
|
| 4 |
A study in healing the wounds of trauma
|
Morgan, Jules
|
|
|
22 |
6 |
p. 472
|
article
|
| 5 |
Autoimmune encephalitis: chasing a moving target
|
Venkatesan, Arun
|
|
|
22 |
6 |
p. 460-462
|
article
|
| 6 |
Boston criteria version 2.0 and non-haemorrhagic presentations
|
Moura, João
|
|
|
22 |
6 |
p. 466
|
article
|
| 7 |
Boston criteria version 2.0 and non-haemorrhagic presentations – Authors' reply
|
Charidimou, Andreas
|
|
|
22 |
6 |
p. 466-467
|
article
|
| 8 |
Correction to Lancet Neurol 2023; 22: 368–69
|
|
|
|
22 |
6 |
p. e8
|
article
|
| 9 |
Correction to Lancet Neurol 2023; 22: 373–74
|
|
|
|
22 |
6 |
p. e8
|
article
|
| 10 |
Correction to Lancet Neurol 2023; 22: 505–16
|
|
|
|
22 |
6 |
p. e8
|
article
|
| 11 |
Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease
|
Dalmau, Josep
|
|
|
22 |
6 |
p. 529-540
|
article
|
| 12 |
Elisaveta Sokolov
|
|
|
|
22 |
6 |
p. 471
|
article
|
| 13 |
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial
|
Pan, Yuesong
|
|
|
22 |
6 |
p. 485-493
|
article
|
| 14 |
Monomania of political strife by Géricault
|
Burgos, Javier S
|
|
|
22 |
6 |
p. 468-469
|
article
|
| 15 |
Neurological research in children: challenges and misconceptions
|
Sanger, Terry
|
|
|
22 |
6 |
p. 474-475
|
article
|
| 16 |
Peter Goadsby: knowledge of politics, politics of knowledge
|
Burton, Adrian
|
|
|
22 |
6 |
p. 470
|
article
|
| 17 |
Rimegepant for migraine: acute efficacy beyond the USA
|
Mitsikostas, Dimos D
|
|
|
22 |
6 |
p. 456-457
|
article
|
| 18 |
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
|
Yu, Shengyuan
|
|
|
22 |
6 |
p. 476-484
|
article
|
| 19 |
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
|
Furr Stimming, Erin
|
|
|
22 |
6 |
p. 494-504
|
article
|
| 20 |
Stroke care quality—why recognition matters
|
Van Der Merwe, Jan
|
|
|
22 |
6 |
p. 471
|
article
|
| 21 |
Targeting tau degradation: a viable therapeutic approach?
|
Mason, Matthew
|
|
|
22 |
6 |
p. 462-464
|
article
|
| 22 |
The Brain Research Africa Initiative (BRAIN)
|
Njamnshi, Alfred K
|
|
|
22 |
6 |
p. 467-468
|
article
|
| 23 |
The complexities underlying epilepsy in people with glioblastoma
|
Sokolov, Elisaveta
|
|
|
22 |
6 |
p. 505-516
|
article
|
| 24 |
Traumatic brain injury as a chronic disease: insights from the United States Traumatic Brain Injury Model Systems Research Program
|
Dams-O'Connor, Kristen
|
|
|
22 |
6 |
p. 517-528
|
article
|
| 25 |
Treatment for Alzheimer's disease: time to get ready
|
The Lancet Neurology,
|
|
|
22 |
6 |
p. 455
|
article
|
| 26 |
Valbenazine as treatment for Huntington's disease chorea
|
Heim, Beatrice
|
|
|
22 |
6 |
p. 459-460
|
article
|
Journal description